March 5, 2019
FDA issues Safety Communication on using surgical robots in women’s health
Editor's Note
The Food and Drug Administration (FDA) on February 28 issued a Safety Communication on the safety and effectiveness of using robotically-assisted surgical devices in mastectomy procedures or in the prevention or treatment of cancer in women.
The FDA cited limited, preliminary evidence that the use of robotically-assisted surgical devices for treatment or prevention of cancers that primarily (breast) or exclusively (cervical) affect women may be linked to diminished long-term survival.
Free Daily News
- FBI investigates as Oracle health data breach exposes patient information
- Study: Pulse oximeters may misestimate oxygen saturation in darker skin tones
- FDA issues Class 1 recall for vascular cannulas
- Renewed push for healthcare price transparency faces familiar challenges
- Survey: Tariffs expected to increase hospital costs, disrupt supply chains
- Study: Arthroplasty implants linked to metal accumulation in cerebrospinal fluid
- Novel noninvasive surgical approach shows promise in treating severe OCD
- Study: Preop mental health assessment improves postop outcomes for older patients
- Study: Adenotonsillectomy reduces healthcare use in children with mild sleep-disordered breathing
- Introducing New Leader Toolkit: Your guide to OR leadership success
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement